Construction and validation of nomograms to reduce completion thyroidectomy by predicting lymph node metastasis in low-risk papillary thyroid carcinoma

被引:6
|
作者
Wang, Rong [1 ]
Tang, Zimei [1 ]
Wu, Zhenghao [1 ]
Xiao, Yunxiao [1 ]
Li, Jiexiao [1 ]
Zhu, Junling [1 ]
Zhang, Ximeng [1 ]
Ming, Jie [1 ]
机构
[1] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Breast & Thyroid Surg, 1277 Jiefang Ave, Wuhan 430022, Peoples R China
来源
EJSO | 2023年 / 49卷 / 08期
关键词
Papillary thyroid carcinoma; Completion thyroidectomy; Lymph node metastasis; Nomogram; ASSOCIATION GUIDELINES; RADIOACTIVE IODINE; YOUNG AGE; FOLLOW-UP; CANCER; RECURRENCE; SURVIVAL; NODULES; WELL; SIZE;
D O I
10.1016/j.ejso.2023.03.236
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Context: More than 5 central lymph nodes metastases (CLNM) or lateral lymph node metastasis (LLNM) indicates a higher risk of recurrence in low-risk papillary thyroid carcinoma (PTC) and may lead to completion thyroidectomy (CTx) in patients initially undergoing lobectomy. Objective: To screen potentially high-risk patients from low-risk patients by using preoperative and intraoperative clinicopathological features to predict lymph node status. Methods: A retrospective analysis of 8301 PTC patients in Wuhan Union Hospital database (2009e2021) was performed according to the 2015 American Thyroid Association (ATA) and 2021 National Comprehensive Cancer Network (NCCN) guidelines, respectively. Logistic regression and best subsets regression were used to identify risk factors. Nomograms were established and externally validated using the Differentiated Thyroid Cancer in China cohort. Results: More than 5 CLNM or LLNM was detected in 1648 (19.9%) patients. Two predictive models containing age, gender, maximum tumor size, free thyroxine (FT4) and palpable node (all p < 0.05) were established. The nomogram based on NCCN criteria showed better discriminative power and consistency with a specificity of 0.706 and a sensitivity of 0.725, and external validation indicated that 76% of potentially high-risk patients could achieve preoperative conversion of surgical strategy. Conclusions: Models based on large cohorts with good predictive performance were constructed and validated. Preoperative low-risk (T1-2N0M0) patients with age younger than 40 years, male gender, large tumor size, low FT4 and palpable nodes may be at high risk of LLNM or more than 5 CLNM, and they should receive more aggressive initial therapy to reduce CTx.
引用
收藏
页码:1395 / 1404
页数:10
相关论文
共 50 条
  • [21] Comparison of Lobectomy vs Total Thyroidectomy for Intermediate-Risk Papillary Thyroid Carcinoma With Lymph Node Metastasis
    Xu, Siyuan
    Huang, Hui
    Huang, Ying
    Qian, Jiaxin
    Wang, Xiaolei
    Xu, Zhengang
    Liu, Shaoyan
    Liu, Jie
    JAMA SURGERY, 2023, 158 (01) : 73 - 79
  • [22] The Identification of Intraoperative Risk Factors Can Reduce, but Not Exclude, the Need for Completion Thyroidectomy in Low-Risk Papillary Thyroid Cancer Patients
    Craig, Steven J.
    Bysice, Andrew M.
    Nakoneshny, Steven C.
    Pasieka, Janice L.
    Chandarana, Shamir P.
    THYROID, 2020, 30 (02) : 222 - 228
  • [23] Risk factors for predicting central lymph node metastasis in papillary thyroid microcarcinoma
    Xu, Dequan
    Lv, Xiaoying
    Wang, Song
    Dai, Wenjie
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (09): : 6199 - 6205
  • [24] A nomogram for enhanced risk stratification for predicting cervical lymph node metastasis in papillary thyroid carcinoma patients
    Deng, Lingxin
    Muhanhali, Dilidaer
    Ai, Zhilong
    Zhang, Min
    Ling, Yan
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [25] Trends of the prevalence rate of central lymph node metastasis and multifocality in patients with low-risk papillary thyroid carcinoma after delayed thyroid surgery
    Wang, Pei
    Dong, Zhizhong
    Zhao, Shuyan
    Su, Yanjun
    Zhang, Jianming
    Ma, Yunhai
    Diao, Chang
    Qian, Jun
    Cheng, Ruochuan
    Liu, Wen
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [26] Cystic lymph node metastasis in papillary thyroid carcinoma
    Miseikyte-Kaubriene, Edita
    Trakymas, Mantas
    Ulys, Albertas
    MEDICINA-LITHUANIA, 2008, 44 (06): : 455 - 459
  • [27] Central Lymph Node Metastasis in Papillary Thyroid Carcinoma
    Ashok R. Shaha
    World Journal of Surgery, 2018, 42 : 630 - 631
  • [28] Central Lymph Node Metastasis in Papillary Thyroid Carcinoma
    Shaha, Ashok R.
    WORLD JOURNAL OF SURGERY, 2018, 42 (03) : 630 - 631
  • [29] Construction and validation of a nomogram for predicting lateral lymph node metastasis in pediatric and adolescent with differentiated thyroid carcinoma
    Dan, Jiaqiang
    Tan, Jingya
    Guo, Yao
    Xu, Yang
    Zhou, Lin
    Huang, Junhua
    Yuan, Zhiying
    Ai, Xiang
    Li, Junyan
    ENDOCRINE, 2024, 85 (01) : 196 - 205
  • [30] Development and validation of a novel 14-gene signature for predicting lymph node metastasis in papillary thyroid carcinoma
    Ling, Yuwei
    Jia, Luyao
    Li, Kaifu
    Zhang, Lina
    Wang, Yajun
    Kang, Hua
    GLAND SURGERY, 2021, 10 (09) : 2644 - +